1.
Sureda A, Carrasco M, de Miguel M, Martinez J, Conde E, Sanz M, Diaz-Mediavilla J, Sierra J. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia. Haematologica [Internet]. 2003Nov.1 [cited 2026Nov.20];88(11):1213-20. Available from: https://haematologica.org/article/view/2890